Please assess the completion status of the following clinical trial:

Trial Title: Glucose Uptake in Metabolic Tissues After Bariatric Surgery

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* BMI 35.0-50.0 kg/m2 for obese group and 18.5-24.9 kg/m2 for the lean group~* Must be scheduled for RYGB or SG surgery~Exclusion Criteria:~* Previous bariatric surgery~* Unstable weight (\>4% change during the last 2 months before entering the study)~* Significant organ system dysfunction (e.g., severe pulmonary or kidney disease)~* Cancer or cancer that has been in remission for \<5 years~* Conditions that render subject unable to complete all testing procedures (e.g. metal implants that interfere with imaging procedures; coagulation disorders)~* Use of medications that are known to affect the study outcome measures or increase the risk of study procedures and that cannot be temporarily discontinued for this study~* Pregnant or lactating women~* Persons who are not able to grant voluntary informed consent~* Persons who are unable or unwilling to follow the study protocol or who, for any reason, the research team considers not an appropriate candidate for this study, including non-compliance with screening appointments or study visits

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- RYGB or SG (Type: EXPERIMENTAL): Baseline testing followed by subject's already scheduled RYGB or SG surgery, and then post-testing.
- Lean (Type: NO_INTERVENTION): Lean control subjects doing baseline testing only.

Based on this trial design, predict the completion outcome and termination type (if applicable).